MedCap AB (publ) (STO:MCAP)
Sweden
· Delayed Price · Currency is SEK 392.00
-2.50 (-0.63%)
Feb 21, 2025, 5:29 PM CET
MedCap AB Revenue
In the year 2024, MedCap AB had annual revenue of 1.81B SEK with 12.94% growth. MedCap AB had revenue of 474.20M in the quarter ending December 31, 2024, with 1.13% growth.
Revenue
1.81B
Revenue Growth
+12.94%
P/S Ratio
3.22
Revenue / Employee
3.25M
Employees
556
Market Cap
5.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.81B | 207.00M | 12.94% |
| Dec 31, 2023 | 1.60B | 475.70M | 42.32% |
| Dec 31, 2022 | 1.12B | 197.70M | 21.34% |
| Dec 31, 2021 | 926.30M | 98.30M | 11.87% |
| Dec 31, 2020 | 828.00M | 70.60M | 9.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |